LY88074
Product Specifications
UNSPSC Description
LY88074 (Compound 88074) is a Raloxifene analog lacking the basic side chain. Raloxifene is a selective estrogen receptor modulator, and reduces fracture risk at least in part by improving the mechanical properties of bone in a cell- and estrogen receptor-independent manner[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/ly88074.html
Smiles
O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C31)C4=CC=C(O)C=C4
Molecular Weight
362.40
References & Citations
[1]Bivi N, et al. Structural features underlying raloxifene's biophysical interaction with bone matrix. Bioorg Med Chem. 2016 Feb 15;24(4):759-67.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135585/LY88074-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135585/LY88074-SDS-MedChemExpress.pdf
CAS Number
177744-96-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1135118-01 0.02 mg (E-Coli)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details 
MBS1135118-02 0.1 mg (E-Coli)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details MBS1135118-03 0.02 mg (Yeast)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details MBS1135118-04 0.1 mg (Yeast)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details MBS1135118-05 0.02 mg (Baculovirus)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details MBS1135118-06 0.02 mg (Mammalian-Cell)
Recombinant Brevibacillus brevis Uracil-DNA glycosylase (ung)
Ask
View Details